Abstract 12512: Antithrombotic Strategies According to Age in Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the Augustus Trial

Patrícia O. Guimarães,Renato D. Lopes,Daniel Wojdyla,John H. Alexander,Shaun G. Goodman,Ronald Aronson,Sigrun Halvorsen,Peter Sinnaeve,Dragos Vinereanu,Robert F. Storey,Otavio Berwanger,Stephan Windecker,Roxana Mehran,Christopher B. Granger,Karen P. Alexander

Abstract 12512: Antithrombotic Strategies According to Age in Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the Augustus Trial

2021

Patrícia O. Guimarães
Renato D. Lopes
Daniel Wojdyla
John H. Alexander
Shaun G. Goodman
Ronald Aronson
Sigrun Halvorsen
Peter Sinnaeve
Dragos Vinereanu
Robert F. Storey
Otavio Berwanger
Stephan Windecker
Roxana Mehran
Christopher B. Granger
Karen P. Alexander

Background: In AUGUSTUS, apixaban led to lower rates of bleeding and hospitalization than VKA, and aspirin caused more bleeding than placebo, in patients with AF and ACS and/or PCI treated with a P...

Keywords:

Cardiology
Percutaneous coronary intervention
Atrial fibrillation
Apixaban
Acute coronary syndrome
Placebo
Conventional PCI
Internal medicine
Aspirin
Medicine
Antithrombotic

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations